Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 20/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4425127 | 0.82 | MLYCD (0.72) | MLYCD | |
| SCHEMBL4419678 | 0.80 | MLYCD (1.00) | MLYCD | |
| SCHEMBL4880019 | 0.80 | MLYCD (1.00) | MLYCD | |
| SCHEMBL4880532 | 0.77 | MLYCD (0.67) | MLYCD | |
| SCHEMBL4883782 | 0.76 | MLYCD (0.66) | MLYCD | |
| SCHEMBL4420377 | 0.76 | MLYCD (0.76) | MLYCD | |
| SCHEMBL4420376 | 0.76 | MLYCD (0.76) | MLYCD | |
| Trifluoroacetic Acid SCHEMBL4426286 | 0.75 | MLYCD (0.64) | MLYCD | |
| SCHEMBL4422419 | 0.74 | MLYCD (0.67) | MLYCD | |
| SCHEMBL4427643 | 0.73 | MLYCD (1.00) | MLYCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080070869-A1 | Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-03-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070869-A1 | Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators | MLYCD, ME3, ACACA | MLYCD 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.